Department of Otolaryngology and Laryngological Oncology, 2nd Chair of Otolaryngology, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland.
Eur Arch Otorhinolaryngol. 2013 Jul;270(7):2045-50. doi: 10.1007/s00405-012-2311-1. Epub 2012 Dec 22.
The aim of the study was to assess the effect of three different types of anaesthesia on perioperative bleeding control and to analyse the mean arterial blood pressure and heart rate in patients undergoing endoscopic paranasal sinus surgery. Ninety patients (30 women and 60 men, aged 18-85 years) scheduled to undergo functional endoscopic sinus surgery in the years 2008-2010 were identified as candidates for inclusion in the study. Patients were randomly assigned to one of three groups (30 patients each) according to the type of general anaesthesia to be administered. Groups I and II both received inhalation anaesthesia (sevoflurane for sedation) and intravenous anaesthesia (fentanyl in group I, remifentanil in group II). Anaesthesia was delivered solely via intravenous route (TIVA) in group III, with propofol used for sedation and remifentanil for analgesia. Blood pressure and heart rate were monitored during surgery and post-surgically for 4 h. Mean anaesthesia duration in groups I, II and III was 108.7 ± 20.8, 112.6 ± 22.2 and 103.7 ± 17.5 min and the surgery duration was 71.3 ± 16.7, 78.8 ± 24.2 and 66.5 ± 15.5 min, respectively. Mean blood loss during surgery was 365.0 ± 176.2, 340.0 ± 150.5 and 225.0 ± 91.7 ml, with a mean blood loss rate of 5.1 ± 2.4, 4.5 ± 2.2 and 3.4 ± 1.1 ml/min in groups I, II and III, respectively. Technologically advanced control of the drug dose with the TIVA technique allows for better control of perioperative bleeding.
本研究旨在评估三种不同类型的麻醉对围手术期出血控制的影响,并分析接受鼻内镜鼻窦手术患者的平均动脉血压和心率。
2008 年至 2010 年间,90 名(30 名女性和 60 名男性,年龄 18-85 岁)计划接受功能性鼻内镜鼻窦手术的患者被确定为纳入研究的候选者。患者根据将要接受的全身麻醉类型随机分为三组(每组 30 名患者)。第 I 组和第 II 组均接受吸入麻醉(七氟醚镇静)和静脉麻醉(第 I 组芬太尼,第 II 组瑞芬太尼)。第 III 组仅通过静脉途径(TIVA)给予麻醉,使用丙泊酚镇静和瑞芬太尼镇痛。在手术中和手术后 4 小时监测血压和心率。第 I、II 和 III 组的平均麻醉持续时间分别为 108.7±20.8、112.6±22.2 和 103.7±17.5 分钟,手术持续时间分别为 71.3±16.7、78.8±24.2 和 66.5±15.5 分钟。手术过程中的平均失血量分别为 365.0±176.2、340.0±150.5 和 225.0±91.7ml,失血量率分别为 5.1±2.4、4.5±2.2 和 3.4±1.1ml/min,第 I、II 和 III 组。TIVA 技术的药物剂量的先进控制技术可以更好地控制围手术期出血。